Cargando…
Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma
BACKGROUND: This prospective, open-label phase II study assessed the impact of liver-directed therapy with selective internal radiation therapy (SIRT) and systemic chemotherapy on progression-free survival (PFS) in liver-dominant metastatic pancreatic adenocarcinoma. METHODS: Patients received yttri...
Autores principales: | Gibbs, Peter, Do, Cuong, Lipton, Lara, Cade, David N., Tapner, Michael J., Price, David, Bower, Geoff D., Dowling, Richard, Lichtenstein, Meir, van Hazel, Guy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624193/ https://www.ncbi.nlm.nih.gov/pubmed/26503593 http://dx.doi.org/10.1186/s12885-015-1822-8 |
Ejemplares similares
-
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study
por: Gibbs, Peter, et al.
Publicado: (2014) -
Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma
por: Cao, Shuhui, et al.
Publicado: (2018) -
Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma
por: Suda, Kenichi, et al.
Publicado: (2014) -
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy
por: Lim, L, et al.
Publicado: (2005) -
A global assessment of the male predominance in esophageal adenocarcinoma
por: Xie, Shao-Hua, et al.
Publicado: (2016)